Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Nokian Renkaa (PK) NKRKF

Alternate Symbol(s):  NKRKY

Nokian Renkaat Oyj develops and manufactures tires for passenger cars, trucks, and heavy machineries in Nordics, the rest of Europe, the Americas, and internationally. It operates through Passenger Car Tyres, Heavy Tyres, and Vianor Tire Chain segments. The company develops and produces winter, summer, and all-season tires for passenger cars, SUVs, and vans; tires for forestry machinery; special tires for agricultural machinery, tractors, and industrial machinery; and engages in retreading and truck tire business. It also sells car and van tires, as well as truck tires under the Nokian Tyres and other tire brands; other automotive products and services; and operates Vianor service centers. The company distributes its products through Vianor chain, Vianor Partner chain, Nokian Tyres Authorized Dealers network, as well as through tire dealers, car dealerships, and vehicle manufacturers, and online stores. Nokian Renkaat Oyj was founded in 1898 and is headquartered in Nokia, Finland.


PINL:NKRKF - Post by User

User Avatar Image
(3)
•••
  • CoressPringsX
Post by CoressPringson Jun 03, 2022 4:07am
82 Views
Post# 34728677

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance



FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance
 
FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.


<< Previous
Bullboard Posts
Next >>